Marksans Pharma Ltd.

Financial

	Marksans Pharma	Procter&Gamble Healt	FDC
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	25.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	13.0 .	n/a	n/a
R&D as a % of Total Sales	2.2 %	n/a	2.06 %
Financials
5 yr Average ROE	17.57 %	30.46 %	13.66 %
5yr average Equity Multiplier	1.33	2.99	1.57
5yr Average Asset Turnover Ratio	0.9	0.57	0.54
5yr Avg Net Profit Margin	14.56 %	17.93 %	16.24 %
Price to Book	4.18	18.24	3.41
P/E	27.12	38.99	28.45
5yr Avg Cash Conversion Cycle	71.65 Days	-158.56 Days	-14.0 Days
Inventory Days	89.77 Days	36.98 Days	59.23 Days
Days Receivable	65.99 Days	29.14 Days	21.91 Days
Days Payable	88.81 Days	177.2 Days	86.54 Days
5yr Average Interest Coverage Ratio	38.03	337.3	93.3
5yr Avg ROCE	21.95 %	19.93 %	14.95 %
5yr Avg Operating Profit Margin	20.32 %	24.91 %	18.97 %
5 yr average Debt to Equity	0.02	0.0	0.0
5yr CAGR Net Profit	10.03 %	-4.58 %	4.94 %
5yr Average Return on Assets	13.19 %	10.24 %	8.73 %
Shareholdings
Promoter Holding	43.87 %	51.82 %	69.66 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-4.38 %	0.0	0.16 %
Change in Mutual Fund Holding (3 Yrs)	2.6 %	4.04 %	1.1 %

Business

	Marksans Pharma	Procter&Gamble Healt	FDC
Product Wise Break-Up	Product Wise Break-Up Pain Management 44.0 Cough and colds 14.0 Cardiac Science 9.2 Gastro Intestinal 8.5 Central Nervous System (CNS) 8.1 Anti - Diabetes 1.6 Vitamins & Suppliments 0 Anti-Cancer 0 Anti-Hair Fall 0 Antibiotics 0 Anti-allergic 0 Miscellaneous 0 Bulk Drugs 0 Formulation 0 Others 14.6	-	Product Wise Break-Up Central Nervous System (CNS) 0 Pain Management 0 Anti-Hair Fall 0 Anti-Cancer 0 Antibiotics 0 Miscellaneous 0 Anti - Diabetes 0 Cardiac Science 0 Vitamins & Suppliments 0 Bulk Chemicals 14.47 Cough and colds 0 Gastro Intestinal 0 Anti-allergic 0 Formulations 85.53
Location Wise Break-Up	Location Wise Break-Up North America 47.1 Europe 39.3 Australia 9.6 India 0 International 0 Domestic 0 Ethiopia 0 Hong Kong 0 Malaysia 0 Japan 0 New Zealand 0 Nepal 0 Singapore 0 United Kingdom 0 Denmark 0 USA 0 Others 4.0	Location Wise Break-Up Nepal 0 International 8.04 Malaysia 0 Singapore 0 United Kingdom 0 Domestic 91.96 USA 0 North America 0 Ethiopia 0 New Zealand 0 Hong Kong 0 Denmark 0 Australia 0 India 0 Europe 0 Japan 0	Location Wise Break-Up Nepal 0 International 0 Malaysia 0 Singapore 0 United Kingdom 0 Domestic 0 USA 7.76 North America 0 Ethiopia 0 New Zealand 0 Hong Kong 0 Denmark 0 Australia 0 India 80.77 Europe 0 Japan 0 Others 11.47
Customer Segment	Customer Segment OTC 78.8 Rx 21.2	-	-